Adial Pharmaceuticals, Inc. (ADIL)
2.30
-0.05
(-2.13%)
USD |
NASDAQ |
May 21, 16:00
2.37
+0.07
(+3.04%)
After-Hours: 19:59
Adial Pharmaceuticals EPS Diluted (Quarterly) : -1.476 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.022M |
| Total Expenses (Quarterly) | 2.022M |
| Enterprise Value | -2.028M |
| Earnings Yield | -430.6% |
| Normalized Earnings Yield | -430.63 |